New Report Examines How To Launch A Medicine Or A Product In French Pharmacies
Main Category: Pharma Industry / Biotech IndustryArticle Date: 17 Aug 2008 - 0:00 PDT
| Patient / Public: | ![]() |
1 (1 votes) |
| Healthcare Prof: | ![]() |
Research and Markets has announced the addition of the "Launching a Medicine or a Product in French Pharmacies" report to their offering.
Many foreign companies would like to sell their products, medicinal or not, to French pharmacies but do not know how about doing so.
This study describes in detail:
- What the different regulatory statuses are
- How the distribution of drugs is organized in France
- What sales force they can rely on
- Who the wholesalers are and what do they have to offer
- Who they can depend on to manage their logistics
Products Mentioned:
-OTC products
-Medical devices
-Parapharmacy products
Key Topics Covered: -French environment
A short introduction to: the legal status of various products, the pharmaceutical monopoly on medicines, the economic has chosen to outsource. Typology, services, cost, turnover, type of portfolio, list of all key players.
-Depositaries
Laboratories can distribute their pharmaceutical products themselves, or they can rely on external help, namely depositaries. Regulation, services, link with wholesalers, cost, list of all key depositaries.
-Pharmacy coops
Pharmacies unite in groups to build their strength. History, regulations, services, strategies, role of group purchasing organizations, logistics, link with wholesalers.
- Wholesalers
Wholesalers are the interface between laboratories and pharmacies. They buy goods from laboratories and distribute them to each pharmacy. Regulations, market organization, other services such as call centres, depositaries, direct sales networks, software designers, list of all key wholesalers.
-Recommendations
How to optimize the use of each trade channel depending of the type of medicine (reimbursed, non-reimbursed), and the type of products (medicine, medical device, dermocosmetics, food supplements, etc.).
- Methodology
Companies Mentioned:
- AFIPA
- AFSSAPS
- Alliance Healthcare
- Alphega
- Arvem
- Call marketing
- Cedel Pharma
- Ceido
- Celtipharm
- Cerp Lorraine
- Cerp Rhin Rhone Mediterranee
- Cerp Rouen
- CMC
- Coop. Pharmacien Ile de France
- CSP
- Depolabo
- Depolabo
- DFG Performance
- DGX
- Direct Log
- Direct Medica
- Dynapharm
- Etradi
- Eurodep
- Europharmacie
- Evolupharm
- Evrard DPE
- ForumSante
- Geodis
- Giphar
- Giropharm
- Idim
- La Semes
- MBO Pharma,
- Nepenthes
- OCP
- Optipharm
- Performance Directe
- Pharmactiv
- PharmaDep
- Pharmareference
- Pharminov
- PharmUp
- Phoenix Pharma
- Plus pharmacie
- PMS
- Premiere Ligne
- Pressuma
- SOFIP,
- Teleperformance Rhone Alpes
- Vivactis
For more information visit www.researchandmarkets.com/research/7d5871/launching_a_medici.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/118407.php>
APA
http://www.medicalnewstoday.com/releases/118407.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




